Antimuscarinics and the Overactive Detrusor—Which Is the Main Mechanism of Action?
4 December 2002 | pages 1 - 5
Viewing articles 1-10 of 15
4 December 2002 | pages 1 - 5
Can Predictive Models for Prostate Cancer Patients Derived in the United States of America Be Utilized in European Patients? A Validation Study of the Partin Tables
13 November 2002 | pages 6 - 11
24 December 2002 | pages 12 - 27
Prostate Specific Antigen Doubling Time as Auxiliary End Point in Hormone Refractory Prostatic Carcinoma
28 November 2002 | pages 28 - 30
Tissue Polypeptide-Specific Antigen (TPS) Determinations before and during Intermittent Maximal Androgen Blockade in Patients with Metastatic Prostatic Carcinoma
13 November 2002 | pages 31 - 38
Prognostic Significance of Tumor Volume after Radical Prostatectomy: A Multivariate Analysis of Pathological Prognostic Factors
6 November 2002 | pages 39 - 44
Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase in Renal Cell Carcinoma: Relationship between Histological Parameters and Chemosensitivity to 5-Fluorouracil
13 November 2002 | pages 45 - 52
Gender-Related Differences in Clinical and Pathological Characteristics and Therapy of Bladder Cancer
15 November 2002 | pages 53 - 62
24 December 2002 | pages 63 - 69
New Percutaneous Technique of Sacral Nerve Stimulation Has High Initial Success Rate: Preliminary Results
16 November 2002 | pages 70 - 74
Viewing articles 1-10 of 15